“We expect to become an EPS growth story.”

In context

“events. Right? So to prepare for that, we had a significant number of new launches that they are growing, and we did significant business development. But it is growing because they were all early assets what we bought. So they were, let's say, having in front of them the growth period. So what we project, it is that those growing assets will offset the LOEs in 2026, 2027, 2028 more or less. So and then following that, because, of course, LOEs are a one-time event, they continue growing. And then we have a significant step up in the growth when the last LOE is going out. Now what is our strategy in addition to having business development? And new product launches? As we know that with the LOEs, are not going to be a strong top-line growth story for the next three years. Given the delays. We expect to become an EPS growth story. And this is why you see here right now the very acute focus on our improvement of margins. Also, we expect even more importantly, that will be a pipeline story during the next three years. We are very focused on the R&D productivity. We have learned from past mistakes in the R&D productivity. We are moving with very decisive steps to bring new phase three studies. And I think once the studies start, also people will start modeling in their models or upgrading their probabilities of success as we are moving to phase three studies, to reflect what I just told you that as the pipeline matures, the growth post-2028 should look, among the top tier of the industry. So that's more or less the strategy. Now within that, we have $10 to $15 billion of capital to allocate. But we are very prudent in”